WO2025002591 - 5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE FOR THE PROPHYLAXIS AND TREATMENT OF THROMBOTIC DISORDERS
National phase entry is expected:
Publication Number
WO/2025/002591
Publication Date
02.01.2025
International Application No.
PCT/EP2024/000037
International Filing Date
28.06.2024
Title **
[English]
5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE FOR THE PROPHYLAXIS AND TREATMENT OF THROMBOTIC DISORDERS
[French]
5-AMINO-2,3-DIHYDRO-1,4-PHTALAZINEDIONE POUR LA PROPHYLAXIE ET LE TRAITEMENT DE TROUBLES THROMBOTIQUES
Applicants **
METRIOPHARM AG
Europaallee 41
8021 Zürich, CH
Inventors
BRYSCH, Wolfgang
Rabenhorststr. 7
13505 Berlin, DE
KAISER, Astrid
Gerstnerweg 2
12305 Berlin, DE
SAGER, Petra
Steinkleeweg 4
13158 Berlin, DE
SCHUMANN, Sara
Hauptstr. 1
14554 Seddiner See, DE
VON WEGERER, Jörg
Ruhlebener Str. 20
13597 Berlin, DE
Priority Data
23000092.9
29.06.2023
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1186 | |
| EPO | Filing, Examination | 4943 | |
| Japan | Filing | 597 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 3310 |
Total: 10611 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present disclosure refers to 5-amino-2,3-dihydro-1,4-phthalazinedione and its pharmaceutically acceptable salts for the prophylaxis or treatment of thrombotic disorders. The invention relates in particular to the use of 5-amino-2,3-dihydro-1,4-phthalazinedione sodium salt for this purpose. Pharmaceutical compositions, advantageous formulation techniques and a method of treatment are disclosed.[French]
La présente divulgation concerne la 5-amino-2,3-dihydro-1,4-phtalazinedione et ses sels pharmaceutiquement acceptables pour la prophylaxie ou le traitement de troubles thrombotiques. L'invention concerne en particulier l'utilisation de sel de sodium de 5-amino-2,3-dihydro-1,4-phtalazinedione à cet effet. L'invention concerne des compositions pharmaceutiques, des techniques de formulation avantageuses et un procédé de traitement.